Drug Target Review
JULY 7, 2025
7 This initiative forms part of a broader effort to modernise drug development and align regulatory expectations with emerging new approach methodologies (NAMs), including human cell-based assays, artificial intelligence models and organ-on-chip platforms. In silico toxicology: computational methods for predicting toxicity.
PerkinElmer
SEPTEMBER 8, 2019
The structure of HTRF reagents also makes assays highly resistant to most experimental conditions, and particularly well suited for cell-based assays. The post Expanding Your Assay Specificity: Cisbio Joins PerkinElmer first appeared on PerkinElmer Blog. Learn more about Cisbio here.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The ChEMBL-og
OCTOBER 12, 2020
ChEMBL contains a broad range of binding, functional and ADMET type assays in formats ranging from in vitro single protein assays to anti proliferative cell-based assays. Some variation is expected, even for very similar assays, since these are often performed by different groups and institutes.
PerkinElmer
JANUARY 7, 2020
Download the whitepaper to learn more about cell-based assays and what to consider as you design yours. The post Assays for the Future of Drug Discovery first appeared on PerkinElmer Blog. By assessing residence time, failure further down the drug discovery workflow can be avoided.
Molecular Design
JUNE 8, 2023
As the start of the post, I did mention some errors that you don’t want to be making if cheminformatics is your day job and regular readers of this blog will have already guessed that I’m talking about ligand efficiency (LE).
FDA Law Blog: Drug Discovery
FEBRUARY 2, 2023
The definition goes on to list potential options for such tests: cell-based assays, organ chips and microphysiological systems, computer modeling, other nonhuman or human biology-based test methods such as bioprinting, as well as animal tests. FDORA § 3209(a)(2).
The Premier Consulting Blog
APRIL 3, 2024
Part 2 of this blog series includes a more in-depth discussion on analytical procedure control strategy, and the benefits of the enhanced approach in the lifecycle management and post-approval changes of analytical procedures. Technology Selection Description of which technology was selected (HPLC, SDS-PAGE, cell-based assay, ELISA, etc.)
Expert insights. Personalized for you.
52 
Let's personalize your content